REGENERATE STEM CELL THERAPY
ZandCell – REGENERATE STEM CELL THERAPY
ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.
ZandCell(est. 2005) offers stem cell therapy for a wide range of conditions and diseases. We use adult, mesenchymal and embryonic stem cells in our treatments. Our stem cells are taken from the patient, donors or grown in laboratories.
These can be from placenta, amnion, embryo(lab grown only), umbilical cord, bone marrow and fat tissues. All our stem cells are from GMP/GLP/ISO certified companies.
We use a unique patented method in our regenerate therapy that has had great success when treating different diseases.
The embryonic stem cells we work with are pluripotent. A pluripotent cell can create all cell types in the body.
Our stem cell treatments are not affected by the present legislative fight regarding embryonic stem cells from embryos (fetal stem cells), since the embryonic stem cells used by us come from adults.
Until today we have treated more then 9400 patients with great success. We are redefining medicine with our regenerate technology.
Put your trust in us and we promise you we will improve your quality of life!
– ZandCell clinics and our partners around the world currently treat patients with the following (degenerative) diseases:
Remember that every clinic or hospital we use has its own specialist and the success rate is different for every disease.
- Alzheimer’s disease
- Brain injury
- Cell Regeneration treatment – (following chemotherapy and radiotherapy)
- Cardiovascular diseases
- Cerebral Palsy
- Diabetes mellitus (type 1 & type 2)
- Erectile dysfunction (ED)
- Fascioscapulohumeral Dystrophy (FSH)
- Leber’s Congenital Amaurosis
- Macular degeneration
- Muscular Dystrophy
- Multiple Sclerosis (MS)
- Parkinson’s disease
- Post radiation/chemo stem cells therapy
- Retinitis Pigmentosa
- Spinal cord injuries
- Stargardt Disease
- Usher’s Syndrome
For further questions, please contact us.